XML 57 R47.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Divestitures (Details)
$ in Millions
3 Months Ended 12 Months Ended
Nov. 29, 2022
USD ($)
Mar. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Mar. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Oct. 01, 2023
product
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                
Proceeds from sale of assets and subsidiaries   $ 240.6   $ 0.0        
Other Nonoperating Income (Expense)   139.1   69.9        
Gain (Loss) on Disposition of Business   70.4   0.0        
Biocon Biologics                
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                
Equity Securities, FV-NI, Gain (Loss)   (46.9)   2.6        
Licensing Agreements                
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                
Write down of intangible assets       32.0 $ 172.9      
Disposal Group, Held-for-Sale, Not Discontinued Operations                
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                
Assets held for sale   1,846.5 $ 1,946.0       $ 1,946.0  
Disposal Group, Disposed of by Sale, Not Discontinued Operations                
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                
Number Of Women's Healthcare Products Sold | product               2
Upjohn Distributor Markets | Disposal Group, Held-for-Sale, Not Discontinued Operations                
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                
Asset Impairment Charges         374.2   136.4  
Inventory Valuation Reserves       9.2        
Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal             85.2  
Upjohn Distributor Markets | Disposal Group, Held-for-Sale, Not Discontinued Operations | Inventories                
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                
Asset Impairment Charges         84.3      
Upjohn Distributor Markets | Disposal Group, Held-for-Sale, Not Discontinued Operations | Emerging Markets Segment                
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                
Goodwill, Impairment Loss         $ 117.0      
Biocon Biologics                
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                
Other Nonoperating Income (Expense)   13.4   $ 45.7        
Biocon Biologics | Scenario, Forecast | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement                
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                
Divestiture of Business, Deferred Cash Consideration.           $ 335.0    
Biocon Biologics | Disposal Group, Disposed of by Sale, Not Discontinued Operations                
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                
Disposal Group, Including Discontinued Operation, Consideration $ 3,000.0              
Proceeds from sale of assets and subsidiaries 2,000.0              
Noncash or Part Noncash Divestiture, Amount of Consideration Received $ 1,000.0              
Disposal Group, Including Discontinued Operation, Ownership Percentage in Disposed Asset 12.90%              
Disposal Group, Including Discontinued Operations, Contingent Consideration Liability, Working Capital Adjustment $ 250.0              
Disposal Group, Including Discontinued Operations, Contingent Consideration Paid             220.0  
Women's Health Products | Disposal Group, Disposed of by Sale, Not Discontinued Operations | Other Income                
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                
Gain (Loss) on Disposition of Business             80.8  
Women's Health Products | Disposal Group, Disposed of by Sale, Not Discontinued Operations | Selling, General and Administrative Expenses                
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                
Gain (Loss) on Disposition of Business             $ 156.2  
OTC Business | Disposal Group, Held-for-Sale, Not Discontinued Operations                
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                
Asset Impairment Charges     734.7          
Goodwill, Impairment Loss     580.1          
Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down     $ 154.7          
API Business | Disposal Group, Held-for-Sale, Not Discontinued Operations                
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                
Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down   $ 10.4